SB0781

2013 Regular Session

 

Entitled:

Pharmacists - Biosimilar Biological Products - Substitutions

Sponsored by:

Senator Conway

Status:

In the House - Hearing 4/04 at 1:00 p.m.


Synopsis:Authorizing pharmacists to substitute biosimilar biological products for prescribed biological reference products only under specified circumstances; requiring pharmacists or their designees to give specified notices and record specified information if the pharmacist substitutes an interchangeable biosimilar biological product for a prescribed biological reference product; etc.
Analysis:Fiscal and Policy Note (Revised)
All Sponsors:Senator Conway
Additional Facts:Bill File Type: Regular
Effective Date(s): October 1, 2013
Committee(s):
Education, Health, and Environmental Affairs  Listen to Committee HearingHealth and Government Operations  View Committee Hearing
Broad Subject(s):Health Occupations
Narrow Subject(s):Drugs -see also- Controlled Dangerous Sub; Substance Abuse
Health Occupations -see also- specific health occupations
Labeling
Liability -see also- Good Samaritan
Notices
Pharmacists and Pharmacies
Records -see also- Land Records; Vital Records
Statutes:Article - Health Occupations
(12-101, 12-504, 12-504.1)

How a Bill Becomes Law

Legislative Lingo

Explanation of Floor Motions and Actions


October 24, 2017 1:10 P.M.